Characterised by mutations in the hepatic enzyme phenylalanine hydroxylase (PAH), PKU is one of the most prevalent inborn metabolic disorders, with reported incidence rates around 1 in every 10,000 births [1]. Here, PAH is linked to phenylketonuria.